Document is current
Any future updates will be listed below
-
Authors
Holst, Theresa
Dierks, Alexander
Patt, Marianne
Wienand, Georgine
Müller, Lisa
Pfob, Christian H.
Kircher, Malte
Stock, Sina
Lapa, Constantin
Girdauskas, Evaldas
Bundschuh, Ralph A.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Augsburg
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 19 September 2025
First Online: 3 April 2026
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and with national regulations and was approved by the local institutional review board (review board of the Ludwig-Maximilians-Universität München, Munich, Germany) on 06 September 2024 (permit number 24–0731). Informed consent was obtained from all subjects reported in the study prior to the imaging and therapeutic procedures.
: Not applicable.
: CL reports prior consulting activities for Blue Earth Diagnostics Ltd. (BED, Oxford, UK) and Novartis (Nürnberg, Germany). RAB is a consultant for and has received speaker´s honoraria from Bayer Healthcare (Leverkusen, Germany), Novartis (Nürnberg, Germany) and Eisai GmbH (Frankfurt, Germany) and has received travel expenses from Blue Earth Diagnostics Ltd. (BED, Oxford, UK). No other potential conflicts of interest relevant to this article exist.
